PubMed

Brief communication: rituximab in HIV-associated multicentric Castleman disease.

Bower M, Powles T, Williams S, Davis TN, Atkins M, Montoto S, Orkin C, Webb A, Fisher M, Nelson M, Gazzard B, Stebbing J, Kelleher P.

Ann Intern Med. 2007 Dec 18;147(12):836-9.PMID: 18087054 [PubMed - indexed for MEDLINE]Related articlesFree article

Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease.

Bower M, Veraitch O, Szydlo R, Charles P, Kelleher P, Gazzard B, Nelson M, Stebbing J.

Blood. 2009 May 7;113(19):4521-4. Epub 2009 Feb 17.PMID: 19224759 [PubMed - indexed for MEDLINE]Related articles

Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.

Neuville S, Agbalika F, Rabian C, Brière J, Molina JM.

Am J Hematol. 2005 Aug;79(4):337-9.PMID: 16044438 [PubMed - indexed for MEDLINE]Related articles

Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.

Gérard L, Bérezné A, Galicier L, Meignin V, Obadia M, De Castro N, Jacomet C, Verdon R, Madelaine-Chambrin I, Boulanger E, Chevret S, Agbalika F, Oksenhendler E.

J Clin Oncol. 2007 Aug 1;25(22):3350-6.PMID: 17664482 [PubMed - indexed for MEDLINE]Related articles

Rituximab therapy for HIV-associated Castleman disease.

Marcelin AG, Aaron L, Mateus C, Gyan E, Gorin I, Viard JP, Calvez V, Dupin N.

Blood. 2003 Oct 15;102(8):2786-8. Epub 2003 Jul 3.PMID: 12842986 [PubMed - indexed for MEDLINE]Related articlesFree article

Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease.

Powles T, Stebbing J, Montoto S, Nelson M, Gazzard B, Orkin C, Webb A, Bower M.

Blood. 2007 Dec 1;110(12):4132-3. No abstract available. PMID: 18024800 [PubMed - indexed for MEDLINE]Related articlesFree article

Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.

Stary G, Kohrgruber N, Herneth AM, Gaiger A, Stingl G, Rieger A.

AIDS. 2008 Jun 19;22(10):1232-4. No abstract available. PMID: 18525273 [PubMed - indexed for MEDLINE]Related articles

Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.

Casquero A, Barroso A, Fernández Guerrero ML, Górgolas M.

Ann Hematol. 2006 Mar;85(3):185-7. Epub 2005 Dec 10.PMID: 16341862 [PubMed - indexed for MEDLINE]Related articles

Castleman disease in an HIV-infected patient with Kaposi sarcoma.

Saif MW.

AIDS Read. 2001 Nov;11(11):572-6.PMID: 11789020 [PubMed - indexed for MEDLINE]Related articles

Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.

Simonelli C, Tedeschi R, Gloghini A, Talamini R, Bortolin MT, Berretta M, Spina M, Morassut S, Vaccher E, De Paoli P, Carbone A, Tirelli U.

J Med Virol. 2009 May;81(5):888-96.PMID: 19319955 [PubMed - indexed for MEDLINE]Related articles

Multicentric Castleman's disease in HIV infection: a systematic review of the literature.

Mylona EE, Baraboutis IG, Lekakis LJ, Georgiou O, Papastamopoulos V, Skoutelis A.

AIDS Rev. 2008 Jan-Mar;10(1):25-35. Review.PMID: 18385778 [PubMed - indexed for MEDLINE]Related articles

HIV-associated multicentric Castleman disease.

Oksenhendler E.

Curr Opin HIV AIDS. 2009 Jan;4(1):16-21. Review.PMID: 19343828 [PubMed - indexed for MEDLINE]Related articles

Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.

Ide M, Kawachi Y, Izumi Y, Kasagi K, Ogino T.

Eur J Haematol. 2006 Feb;76(2):119-23.PMID: 16405432 [PubMed - indexed for MEDLINE]Related articles

High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel JP, Isaacson PG, Meignin V.

Blood. 2002 Apr 1;99(7):2331-6.PMID: 11895764 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.

Ocio EM, Sanchez-Guijo FM, Diez-Campelo M, Castilla C, Blanco OJ, Caballero D, San Miguel JF.

Am J Hematol. 2005 Apr;78(4):302-5.PMID: 15795923 [PubMed - indexed for MEDLINE]Related articles

Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.

Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, Manganaro D, Fasan M, Moroni M, Galli M, Parravicini C.

Blood. 2001 Dec 1;98(12):3473-5.PMID: 11719390 [PubMed - indexed for MEDLINE]Related articlesFree article

Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: a case series.

Bestawros A, Michel R, Séguin C, Routy JP.

Am J Hematol. 2008 Jun;83(6):508-11.PMID: 18027834 [PubMed - indexed for MEDLINE]Related articles

High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel JP, Agbalika F.

Blood. 2000 Sep 15;96(6):2069-73.PMID: 10979949 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV-associated multicentric Castleman's disease.

Stebbing J, Pantanowitz L, Dayyani F, Sullivan RJ, Bower M, Dezube BJ.

Am J Hematol. 2008 Jun;83(6):498-503. Review.PMID: 18260115 [PubMed - indexed for MEDLINE]Related articles

Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.

Flejsierowicz M, Ahmed MS, Kotov P, Cheng YC.

WMJ. 2008 Jul;107(4):191-4.PMID: 18702436 [PubMed - indexed for MEDLINE]Related articles